These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 4003598)

  • 1. Dexamethasone suppression tests in patients with obsessive-compulsive disorder.
    Lieberman JA; Kane JM; Sarantakos S; Cole K; Howard A; Borenstein M; Novacenko H; Puig-Antich J
    Am J Psychiatry; 1985 Jun; 142(6):747-51. PubMed ID: 4003598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obsessive-compulsive disorder, depression, and the dexamethasone suppression test.
    Jenike MA; Baer L; Brotman AW; Goff DC; Minichiello WE; Regan NJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):182-4. PubMed ID: 3597805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone suppression test and primary obsessional compulsive disorder.
    Vallejo J; Olivares J; Marcos T; Martínez-Osaba MJ; Ribera F; Bulbena A
    Compr Psychiatry; 1988; 29(5):498-502. PubMed ID: 3180759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test in patients with primary obsessive-compulsive disorder.
    Insel TR; Kalin NH; Guttmacher LB; Cohen RM; Murphy DL
    Psychiatry Res; 1982 Apr; 6(2):153-60. PubMed ID: 6953457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal dexamethasone suppression test in primary obsessive-compulsive patients: a confirmatory report.
    Cottraux JA; Bouvard M; Claustrat B; Juenet C
    Psychiatry Res; 1984 Oct; 13(2):157-65. PubMed ID: 6596583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone suppression test in patients with primary obsessive-compulsive disorder and in healthy controls.
    Catapano F; Monteleone P; Maj M; Kemali D
    Neuropsychobiology; 1990; 23(2):53-6. PubMed ID: 2077433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical comparison of Tourette's disorder and obsessive-compulsive disorder.
    Pitman RK; Green RC; Jenike MA; Mesulam MM
    Am J Psychiatry; 1987 Sep; 144(9):1166-71. PubMed ID: 3477103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal dexamethasone suppression test in obsessive-compulsive disorder.
    Monteiro W; Marks IM; Noshirvani H; Checkley S
    Br J Psychiatry; 1986 Mar; 148():326-9. PubMed ID: 3719227
    [No Abstract]   [Full Text] [Related]  

  • 9. Low MMPI diagnostic performance for the DSM-III--R obsessive-compulsive personality disorder.
    Schotte C; De Doncker D; Maes M; Cluydts R; Cosyns P
    Psychol Rep; 1991 Dec; 69(3 Pt 1):795-800. PubMed ID: 1784669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms.
    Greenwald BS; Mathé AA; Mohs RC; Levy MI; Johns CA; Davis KL
    Am J Psychiatry; 1986 Apr; 143(4):442-6. PubMed ID: 3953887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone suppression tests in patients with panic disorder.
    Lieberman JA; Brenner R; Lesser M; Coccaro E; Borenstein M; Kane JM
    Am J Psychiatry; 1983 Jul; 140(7):917-9. PubMed ID: 6859315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and the dexamethasone suppression test in depression.
    Davis KL; Davis BM; Mathé AA; Mohs RC; Rothpearl AB; Levy MI; Gorman LK; Berger P
    Am J Psychiatry; 1984 Jul; 141(7):872-4. PubMed ID: 6731636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary free cortisol levels in obsessive-compulsive disorder.
    Gehris TL; Kathol RG; Black DW; Noyes R
    Psychiatry Res; 1990 May; 32(2):151-8. PubMed ID: 2367600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life for patients with obsessive-compulsive disorder.
    Koran LM; Thienemann ML; Davenport R
    Am J Psychiatry; 1996 Jun; 153(6):783-8. PubMed ID: 8633690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone suppression test and unipolar/bipolar distinctions.
    Zisook S; Janowsky DS; Overall JE; Risch SC
    J Clin Psychiatry; 1985 Nov; 46(11):461-5. PubMed ID: 4055705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone suppression test in hospitalized prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH
    Am J Psychiatry; 1984 Feb; 141(2):290-1. PubMed ID: 6691500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obsessive-compulsive symptoms in panic disorder.
    Mellman TA; Uhde TW
    Am J Psychiatry; 1987 Dec; 144(12):1573-6. PubMed ID: 3688281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone suppression in dementia, depression, and normal aging.
    Georgotas A; McCue RE; Kim OM; Hapworth WE; Reisberg B; Stoll PM; Sinaiko E; Fanelli C; Stokes PE
    Am J Psychiatry; 1986 Apr; 143(4):452-6. PubMed ID: 3953888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test in adolescent outpatients with major depressive disorder.
    Birmaher B; Dahl RE; Ryan ND; Rabinovich H; Ambrosini P; al-Shabbout M; Novacenko H; Nelson B; Puig-Antich J
    Am J Psychiatry; 1992 Aug; 149(8):1040-5. PubMed ID: 1636803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression test in adolescent psychiatric patients.
    Ha H; Kaplan S; Foley C
    Am J Psychiatry; 1984 Mar; 141(3):421-3. PubMed ID: 6703110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.